Pediatric Clinic, Department of Medical and Surgical Sciences, Università degli Studi di Perugia, 06132 Perugia, Italy.
Int J Environ Res Public Health. 2018 Aug 9;15(8):1702. doi: 10.3390/ijerph15081702.
: Imunoglobulin A (IgA) deficiency (IgAD) is the most common form of primary immunodeficiency in Western countries. There have been several reports on IgAD complicated by glomerulonephritis in adults, but only very few cases of IgAD with nephropathy have been reported in children. We present two cases of IgAD with relapsing nephrotic syndrome in pediatric age. : A 4-year-old boy and a 2-year-old boy presented with bilateral periorbital oedema and weight gain. The results of laboratory tests revealed IgAD (IgA < 7 mg/dL), normal creatinine, hypoprotidaemia, hypoalbuminaemia, and nephrotic proteinuria. A diagnosis of IgAD and idiopathic nephrotic syndrome was made, and steroid treatment (prednisone 60 mg/mq/day) was started. During steroid tapering, the children experienced several relapses and to obtain a positive outcome they required therapy with human monoclonal anti-CD20 antibodies (rituximab in the first child, ofatumumab in the second one). : Our cases highlight that IgAD can be observed in nephrotic syndrome and nephropathy in children with IgAD appears to be complicated and difficult to treat with corticosteroids alone. Further research is needed to better describe the clinical manifestations and pathological pictures among subjects with IgAD and nephrotic syndrome to understand whether IgAD has a prognostic value in children with nephrotic syndrome and to let clinical physicians define a more personalized and appropriate approach for the management of these patients.
: 免疫球蛋白 A(IgA)缺陷症(IgAD)是西方国家最常见的原发性免疫缺陷症。已有几例成人 IgAD 合并肾小球肾炎的报道,但儿童中 IgAD 合并肾病的病例非常少。我们报告了两例儿科年龄 IgAD 伴复发性肾病综合征的病例。: 一名 4 岁男孩和一名 2 岁男孩出现双侧眶周水肿和体重增加。实验室检查结果显示 IgAD(IgA <7mg/dL),肌酐正常,低蛋白血症,低白蛋白血症和肾病性蛋白尿。诊断为 IgAD 和特发性肾病综合征,并开始使用类固醇治疗(泼尼松 60mg/mq/天)。在类固醇减量期间,患儿经历了几次复发,为了获得良好的效果,他们需要接受人源化单克隆抗 CD20 抗体治疗(第一例患儿使用利妥昔单抗,第二例患儿使用奥法妥木单抗)。: 我们的病例强调 IgAD 可在儿童肾病综合征中观察到,并且 IgAD 似乎合并肾病时难以单独用皮质类固醇治疗。需要进一步研究以更好地描述 IgAD 合并肾病综合征患者的临床表现和病理图像,以了解 IgAD 是否对儿童肾病综合征具有预后价值,并让临床医生为这些患者制定更个性化和适当的管理方法。